Jonathan Violin insider trades
Open-market stock purchases and sales by Jonathan Violin, Director at Crescent Biopharma, Inc, from SEC Form 4 filings since Feb 28, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 2, 2026 | CBIO Crescent Biopharma, Inc | Bought (not open market) | — |
| May 21, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $25K |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $129K |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $154K |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | — |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $173K |
Companies traded
- CBIO Crescent Biopharma, Inc: other filings, last Jun 2, 2026
- DNTH Dianthus Therapeutics, Inc /DE/: other filings, last May 21, 2026
- ATXS Astria Therapeutics, Inc: other filings, last Jan 23, 2026
- VRDN Viridian Therapeutics, Inc.\DE: 11 sales, last Feb 2, 2023
- CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 2, 2021
- MGEN Miragen Therapeutics, Inc: other filings, last Oct 27, 2020
- TRVN Trevena Inc: other filings, last Feb 28, 2018